The glucose-6-phosphatase system in cancer: from endoplasmic reticulum glucose-6-phosphate flux to stemness, immune escape, and therapeutic vulnerability - Report - MDSpire

The glucose-6-phosphatase system in cancer: from endoplasmic reticulum glucose-6-phosphate flux to stemness, immune escape, and therapeutic vulnerability

  • By

  • Bogdan Alexandru Danalache

  • Abdallah Fallah

  • Frédéric Mercier

  • Borhane Annabi

  • July 17, 2026

Share

Clinical Report: The Role of the Glucose-6-Phosphatase System in Cancer

Overview

The glucose-6-phosphatase (G6Pase) system is implicated in cancer biology, influencing tumor behavior through its regulation of glucose-6-phosphate dynamics. Elevated G6Pase activity in certain cancers correlates with aggressive phenotypes, while its loss in liver and kidney tissues leads to metabolic disruption.

Background

Understanding the G6Pase system is crucial as it plays a significant role in glucose homeostasis and cancer metabolism. The system's components are emerging as potential biomarkers and therapeutic targets across various cancers.

Data Highlights

No numerical data or trial data available in the source material.

Key Findings

  • The G6Pase system regulates intracellular glucose-6-phosphate (G6P) partitioning, impacting cancer cell metabolism.
  • Elevated G6Pase activity is associated with aggressive cancer phenotypes in non-gluconeogenic tumors.
  • Loss of G6PC in liver and kidney tissues leads to metabolic disruption and dedifferentiation.
  • Components of the G6Pase system may serve as biomarkers and therapeutic targets in oncology.
  • Pharmacological and genetic interference with G6PT/SLC37A4 affects glioma cell survival and migration.

Clinical Implications

The findings highlight the metabolic roles of G6P dynamics in tumor behavior and treatment responses.

Conclusion

The G6Pase system represents a critical intersection of metabolism and cancer biology.

Related Resources & Content

  1. Frontiers in Immunology, 2026 -- Glycolytic reprogramming in cancer: immune crosstalk, nutrient competition, and supportive care perspectives
  2. Frontiers in Immunology, 2026 -- Cancer Metabolism: From the Warburg Effect to Precision Therapy
  3. Journal of Gastroenterology, 2025 -- The Critical Function of SFRP2 in Enhancing Glycolysis and Disease Advancement in High-Risk Colorectal Cancer Patients Based on a Glycometabolism Prognostic Model
  4. Frontiers in Immunology, 2026 -- Glycolytic reprogramming in ovarian cancer: mechanisms, immune crosstalk, and therapeutic implications
  5. GeneReviews® - NCBI Bookshelf -- Recommended Surveillance for Individuals with Glycogen Storage Disease Type I
  6. Structures of the human glucose-6-phosphate transporter provide insights into its transport cycle and substrate recognition, 2026
  7. Table 4. [Recommended Surveillance for Individuals with Glycogen Storage Disease Type I]. - GeneReviews® - NCBI Bookshelf
  8. Structures of the human glucose-6-phosphate transporter provide insights into its transport cycle and substrate recognition

Original Source(s)

Related Content